Cannabix TechnologiesBLOZF +4.85%34 PB Ratio is 47.78 as of Jul. 08, 2026, which is 11% above its 10-year median of 42.88. GuruFocus rates BLOZF with a GF Score™ of 34/100. The stock has 2 warning signs investors should review. Among 787 Medical Devices & Instruments companies, Cannabix Technologies ranks worse than 98.73% on this metric.
The historical rank and industry rank for Cannabix Technologies's PB Ratio or its related term are showing as below:
BLOZF'
s PB Ratio Range Over the Past 10 Years
Min: 33.33 Med: 42.88 Max: 59.23
Current: 43
During the past 13 years, Cannabix Technologies's highest PB Ratio was 59.23. The lowest was 33.33. And the median was 42.88.
BLOZF's PB Ratio is ranked worse than 98.73% of 787
companies
in the Medical Devices & Instruments industry
Industry Median: 2.06
vs BLOZF: 43.00
During the past 12 months, Cannabix Technologies's average Book Value Per Share Growth Rate was -50.00% per year.
During the past 3 years, the average Book Value Per Share Growth Rate was -33.80% per year.
During the past 5 years, the average Book Value Per Share Growth Rate was -23.60% per year.
During the past 10 years, the average Book Value Per Share Growth Rate was -10.80% per year.
During the past 13 years, the highest 3-Year average Book Value Per Share Growth Rate of Cannabix Technologies was 140.10% per year. The lowest was -33.80% per year. And the median was -1.60% per year.
Back to Basics: PB Ratio
Cannabix Technologies (OTCPK:BLOZF) PB Ratio Explanation
The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Cannabix Technologies's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Cannabix Technologies PB Ratio vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Cannabix Technologies's PB Ratio distribution charts can be found below:
* The bar in red indicates where Cannabix Technologies's PB Ratio falls into.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.
Cannabix Technologies (BLOZF) has a PB Ratio of 47.78 as of Jul. 08, 2026. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Cannabix Technologies and its competitors. This is 11% above median its historical median of 42.88. Over the past decade, Cannabix Technologies' PB Ratio has ranged from 33.33 to 59.23. According to the industry distribution chart, Cannabix Technologies ranks #777 out of 787 companies in the Medical Devices & Instruments industry, placing it in the top 98.7%.
Is Cannabix Technologies' PB Ratio too high?
Cannabix Technologies' current PB Ratio of 47.78 is 11% above median its 10-year median of 42.88. Over the past 10 years, this metric has ranged from a low of 33.33 to a high of 59.23. The Medical Devices & Instruments industry median PB Ratio is 2.06. Cannabix Technologies' value of 47.78 is 2219.4% above this industry median. Based on the distribution chart, Cannabix Technologies ranks #777 out of 787 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Cannabix Technologies has a GF Score™ of 34/100, reflecting its overall financial health beyond just this single metric.
How does Cannabix Technologies' PB Ratio compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Cannabix Technologies ranks #777 out of 787 companies for PB Ratio. This places Cannabix Technologies in the lower half of its industry. The industry median PB Ratio is 2.06. Cannabix Technologies' value of 47.78 is 2219.4% above this benchmark. Historically, Cannabix Technologies' own PB Ratio has ranged from 33.33 to 59.23 over the past decade. While the company's 10-year median is 42.88 vs. the industry median of 2.06, Cannabix Technologies has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PB Ratio for a Medical Devices & Instruments company?
The median PB Ratio among Medical Devices & Instruments companies is 2.06, based on 787 companies in the industry. Companies in the top quartile (top 25%) have a PB Ratio significantly above this median, while those in the bottom quartile fall well below. However, PB Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Cannabix Technologies's current PB Ratio of 47.78 is 2219.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PB Ratio mean?
A high PB Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Cannabix Technologies and its competitors. For the Medical Devices & Instruments industry, the median PB Ratio is 2.06 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Cannabix Technologies's current PB Ratio is 47.78, which is 11% above median its own 10-year median of 42.88. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cannabix Technologies stock overvalued right now?
Cannabix Technologies (BLOZF) has a current PB Ratio of 47.78. The current PB Ratio is 47.78, which is 11% above median its 10-year median of 42.88 and 2219.4% above the Medical Devices & Instruments industry median of 2.06. Cannabix Technologies' overall GF Score™ is 34/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PB Ratio calculated?
PB Ratio is calculated from a company's financial statements. For Cannabix Technologies (BLOZF), the current PB Ratio is 47.78 as of Jul. 08, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Cannabix Technologies Inc is engaged in the development of marijuana and alcohol breath testing technologies. Its products are Cannabix Marijuana Breath Test and BreathLogix Alcohol Breathalyzer.
34GF Score
Get the complete analysis for BLOZF
PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BLOZF has been successfully added to your 
